Form 8-K - Current report:
SEC Accession No. 0001104659-24-103706
Filing Date
2024-09-27
Accepted
2024-09-27 16:02:19
Documents
13
Period of Report
2024-09-23
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2424982d1_8k.htm   iXBRL 8-K 30682
  Complete submission text file 0001104659-24-103706.txt   207942

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rnaz-20240923.xsd EX-101.SCH 3054
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE rnaz-20240923_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rnaz-20240923_pre.xml EX-101.PRE 22385
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2424982d1_8k_htm.xml XML 3795
Mailing Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109
Business Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109 857-301-6857
Transcode Therapeutics, Inc. (Filer) CIK: 0001829635 (see all company filings)

EIN.: 811065054 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40363 | Film No.: 241334817
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)